Recently, Sandrine Nugteren’s paper, titled “Expression of the immune modulator secretory leukocyte protease inhibitor (SLPI) in colorectal cancer liver metastases and matched primary tumors is associated with a poorer prognosis”, has accepted for publication in OncoImmunology. This is Sandrine’s first paper. Hopefully, there are many more to come.
